Keywords: schering, ag, yasmin, severe, pms, new, oral
Schering AG's Yasmin for severe PMS?
Article | 23 August 2001
Schering AG's new oral contraceptive Yasmin (drospirenone andethinylestradiol) may be an effective therapy for a severe premenstrual syndrome known as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
